✦ LIBER ✦

1495 SERUM ANDROGENS AND THE RISK OF CLINICAL BENIGN PROSTATIC HYPERPLASIA: A COMMUNITY BASED STUDY

✍ Scribed by Parsons, J. Kellogg; Palazzi-Churas, Kerrin; Bergstrom, Jaclyn; Barrett-Connor, Elizabeth

Book ID: 123430368
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 44 KB
Volume: 183
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.02.1232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for clinical benign prostat

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men

✍ James B. Meigs; Beth Mohr; Michael J. Barry; Mary McNaughton Collins; John B. Mc 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Prospective Study of Serum Dihydrotestos

Prospective Study of Serum Dihydrotestosterone and Subsequent Risk of Benign Prostatic Hyperplasia in Community Dwelling Men: The Rancho Bernardo Study

✍ Parsons, J. Kellogg; Palazzi-Churas, Kerrin; Bergstrom, Jaclyn; Barrett-Connor, 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 175 KB

Incidence and risk of treatment for beni

Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: A 15-year longitudinal community-based study

✍ Fukuta, Fumimasa; Masumori, Naoya; Mori, Mitsuru; Tsukamoto, Taiji 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Prostate carcinoma risk subsequent to di

Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia : A population-based cohort study in Sweden

✍ Anand P. Chokkalingam; Olof Nyrén; Jan-Erik Johansson; Gloria Gridley; Joseph K. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract ## BACKGROUND Pathologically, benign prostatic hyperplasia (BPH) is not considered a precursor for prostate carcinoma. However, because the two conditions share not only a similar hormonal environment within the prostate but also several common risk factors, it is possible that men wit

Growth factor, cytokine, and vitamin D r

Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men

✍ Rebecca J. Mullan; Eric J. Bergstralh; Sara A. Farmer; Debra J. Jacobson; Scott 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Clinical Study of the Efficiency and Saf

Clinical Study of the Efficiency and Safety of Afala in Patients with Benign Prostatic Hyperplasia

✍ K. V. Savel’eva; M. V. Kachanova; V. N. Pavlov; R. A. Kazikhinurov; M. Yu. Frolo 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 128 KB